Calcium folinate pentahydrate

Colon Cancer

AkesoSmall moleculePhase 3Active

BB

69/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 71/ 100
Competitive Position: 65/ 100

Competitive context

127 Active assets in the Colon Cancer cohort.

Asset / Sponsor	Phase	Rating
FLUOROURACILUM Akeso	Phase 4	BB
Eloxatin Sun Yat-sen University	Phase 3	BB
Irinotecan SCRI Development Innovations, LLC	Phase 3	BB
MACROGOLS University Medical Center Ho Chi Minh City (UMC)	Phase 4	BB
PANITUMUMAB IFOM ETS - The AIRC Institute of Molecular Oncology	Phase 3	B

View all 50 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant

BBB

Indicative ·

78 / 100

Recurrent Pancreatic CarcinomaDormant

BBB

Indicative ·

78 / 100

Stage IV Colon CancerDormant

BBB

Indicative ·

77 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.